Corbus Pharmaceuticals Holdings, Inc. Operating Cash Flow
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Operating Cash Flow of -$55.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$29.63M.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$25.57M.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$15.92M.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$15.55M.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$64.49M.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$41.79M.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$36.10M.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$37.54M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$29.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$55.20M 10-Q · filed 2026-08-06 | -$71.12M derived: sum of 3 quarters · filed 2026-08-06 | -$86.67M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$25.57M 10-Q · filed 2026-05-12 | -$41.49M derived: sum of 2 quarters · filed 2026-05-12 | -$57.04M derived: sum of 3 quarters · filed 2026-05-12 | -$73.64M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$15.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$31.47M derived: sum of 2 quarters · filed 2026-03-09 | -$48.07M derived: sum of 3 quarters · filed 2026-08-06 | -$64.49M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$15.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$32.15M derived: sum of 2 quarters · filed 2026-08-06 | -$48.57M 10-Q · filed 2025-11-12 | -$59.51M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$16.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$33.02M 10-Q · filed 2026-08-06 | -$43.96M derived: sum of 3 quarters · filed 2026-08-06 | -$57.90M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$16.42M 10-Q · filed 2026-05-12 | -$27.36M derived: sum of 2 quarters · filed 2026-05-12 | -$41.30M derived: sum of 3 quarters · filed 2026-05-12 | -$50.25M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$10.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$24.88M derived: sum of 2 quarters · filed 2026-03-09 | -$33.83M derived: sum of 3 quarters · filed 2026-03-09 | -$41.79M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | -$13.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$22.89M derived: sum of 2 quarters · filed 2025-11-12 | -$30.85M 10-Q · filed 2025-11-12 | -$36.86M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$8.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$16.91M 10-Q · filed 2025-08-05 | -$22.92M derived: sum of 3 quarters · filed 2025-08-05 | -$30.09M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | -$7.97M 10-Q · filed 2025-05-06 | -$7.97M 10-Q · filed 2024-05-07 | -$13.97M derived: sum of 2 quarters · filed 2025-05-06 | -$21.15M derived: sum of 3 quarters · filed 2025-05-06 | -$28.95M derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | -$6.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$13.18M derived: sum of 2 quarters · filed 2025-03-11 | -$20.99M derived: sum of 3 quarters · filed 2025-03-11 | -$36.10M 10-K · filed 2025-03-11 | -$36.10M 10-K · filed 2024-03-12 | |||
| 2023-09-30 | -$7.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$14.98M derived: sum of 2 quarters · filed 2024-11-07 | -$30.09M 10-Q · filed 2024-11-07 | -$30.09M 10-Q · filed 2023-11-07 | -$37.55M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | -$7.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$22.92M 10-Q · filed 2024-08-06 | -$22.92M 10-Q · filed 2023-08-08 | -$30.37M derived: sum of 3 quarters · filed 2024-08-06 | -$37.62M derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | -$15.11M 10-Q · filed 2024-05-07 | -$22.57M derived: sum of 2 quarters · filed 2024-05-07 | -$29.82M derived: sum of 3 quarters · filed 2024-05-07 | -$42.04M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$14.70M derived: sum of 2 quarters · filed 2024-03-12 | -$26.93M derived: sum of 3 quarters · filed 2024-03-12 | -$37.54M 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | -$7.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$19.47M derived: sum of 2 quarters · filed 2023-11-07 | -$30.09M 10-Q · filed 2023-11-07 | -$39.79M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | -$12.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$22.84M 10-Q · filed 2023-08-08 | -$32.55M derived: sum of 3 quarters · filed 2023-08-08 | -$31.69M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | -$10.62M 10-Q · filed 2023-05-09 | -$20.32M derived: sum of 2 quarters · filed 2023-05-09 | -$19.46M derived: sum of 3 quarters · filed 2023-05-09 | -$36.99M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$8.85M derived: sum of 2 quarters · filed 2023-03-07 | -$26.37M derived: sum of 3 quarters · filed 2023-03-07 | -$48.18M 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $856.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$16.67M derived: sum of 2 quarters · filed 2022-11-08 | -$38.48M 10-Q · filed 2022-11-08 | -$56.71M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$17.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$39.34M 10-Q · filed 2022-08-09 | -$57.56M derived: sum of 3 quarters · filed 2022-08-09 | -$84.82M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$21.81M 10-Q · filed 2022-05-10 | -$40.03M derived: sum of 2 quarters · filed 2022-05-10 | -$67.29M derived: sum of 3 quarters · filed 2022-05-10 | -$93.89M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$18.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$45.48M derived: sum of 2 quarters · filed 2022-03-08 | -$72.08M derived: sum of 3 quarters · filed 2022-03-08 | -$99.69M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$27.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$53.86M derived: sum of 2 quarters · filed 2021-11-12 | -$81.46M 10-Q · filed 2021-11-12 | -$104.02M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$26.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$54.21M 10-Q · filed 2021-08-12 | -$76.77M derived: sum of 3 quarters · filed 2021-08-12 | -$93.86M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$27.60M 10-Q · filed 2021-05-13 | -$50.16M derived: sum of 2 quarters · filed 2021-05-13 | -$67.25M derived: sum of 3 quarters · filed 2021-05-13 | -$83.64M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$22.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$39.65M derived: sum of 2 quarters · filed 2021-03-15 | -$56.04M derived: sum of 3 quarters · filed 2021-03-15 | -$45.72M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | -$17.09M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | -$33.48M derived: sum of 2 quarters · filed 2020-11-09 | -$23.16M 10-Q · filed 2020-11-09 | -$37.22M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$16.39M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | -$6.07M 10-Q/A · filed 2020-08-31 | -$20.14M derived: sum of 3 quarters · filed 2020-08-31 | -$28.98M derived: sum of 4 quarters · filed 2020-08-31 | ||||
| 2019-03-31 | $10.32M 10-Q · filed 2020-05-11 | -$3.75M derived: sum of 2 quarters · filed 2020-05-11 | -$12.59M derived: sum of 3 quarters · filed 2020-05-11 | -$18.15M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | -$14.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$22.91M derived: sum of 2 quarters · filed 2020-03-16 | -$28.47M derived: sum of 3 quarters · filed 2020-03-16 | -$30.07M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | -$8.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$14.40M derived: sum of 2 quarters · filed 2019-11-07 | -$16.00M 10-Q · filed 2019-11-07 | -$25.12M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$5.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$7.16M 10-Q · filed 2019-08-08 | -$16.27M derived: sum of 3 quarters · filed 2019-08-08 | -$22.60M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$1.60M 10-Q · filed 2019-05-09 | -$10.71M derived: sum of 2 quarters · filed 2019-05-09 | -$17.05M derived: sum of 3 quarters · filed 2019-05-09 | |||||
| 2017-12-31 | -$9.11M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$15.45M derived: sum of 2 quarters · filed 2019-03-12 | -$27.80M 10-K · filed 2019-03-12 | |||||
| 2017-09-30 | -$6.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$18.68M 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$12.35M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |